Recent Updates
Recently added Catalysts
RDY Neutral Sentiment Score: 55/100

Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN : L85195TG1984PLC004507 Tel : +91 40 4900 2900 Fax : +91 40 4900 2999 Email : mail@drreddys.com www.drreddys.co

Friday, May 17, 2024 1 min read
Key Takeaway: Dr. Reddy's Laboratories announced that the USFDA conducted a routine GMP inspection at its formulations manufacturing facilities in Duvvada, Visakhapatnam, from May 8 to May 17, 2024. The inspection concluded with a Form 483 issued, noting two observations that the company is required to address within a specified timeline. No further details about the nature of the observations were provided in the announcement.

Market Sentiment Analysis

CONCERNS & RISKS

  • The USFDA inspection resulted in a Form 483 with two observations.
  • The company needs to address these observations within a stipulated timeline.

Full Press Release Details

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY-EQ)
BSE Limited (Scrip Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd (Stock Code: DRREDDY)
This is to inform you that the United States Food
& Drug Administration (USFDA) today completed a routine GMP inspection at our formulations manufacturing facilities (FTO-7 & FTO-9)
in Duvvada, Visakhapatnam. The inspection was conducted from 8th May to 17th May, 2024. We have been issued
a Form 483 with two observations, which we will address within the stipulated timeline.
This is for your information and record.
For Dr. Reddy's Laboratories Limited
Company Secretary, Compliance Officer and Head-CSR

Frequently Asked Questions

What is Dr. Reddy's stock code on the NYSE?

Dr. Reddy's stock code on the NYSE is RDY.

When was the USFDA GMP inspection conducted?

The USFDA GMP inspection was conducted from May 8 to May 17, 2024.

How many observations were noted during the inspection?

Two observations were noted in the Form 483 issued after the inspection.

Where are Dr. Reddy's formulations facilities located?

Dr. Reddy's formulations manufacturing facilities are located in Duvvada, Visakhapatnam.

Who issued the compliance report for Dr. Reddy's?

The compliance report was issued by the Company Secretary and Compliance Officer.

Tags: RDY Viatris Investor Conferences Healthcare Dr. Reddy's USFDA GMP inspection Form 483 Visakhapatnam
Last updated: May 17, 2024